NEW YORK (GenomeWeb) –GenomOncology said this week that University Hospitals' Case Medical Center and Seidman Cancer Center will use its GO Clinical Workbench software to launch their first next-generation sequencing-based cancer diagnostic test.
The UH centers will use GenomOncology's GO to manage the workflows they use to analyze raw sequence data all the way through to delivering actionable clinical reports, the company said. The system offers tools for things like checking the quality of sequencing runs and samples, and for annotating and reporting on tumor variants that will "allow us to quickly translate scientific findings into the higher quality patient care," Joseph Willis, division chief of clinical pathology at UH Case Medical Center, said in a statement. Customers can tailor the GO platform to their lab's specific needs and integrate it with existing infrastructure such as laboratory information management systems and so on.
Financial and other terms of the agreement were not disclosed.